SJM
9
-5
WM
74
-5
INTU
58
-3
CAH
48
-6
PFE
14
-7
GD
41
-4
EA
60
-5
IRM
41
3
AEP
54
6
SYY
49
9
VZ
44
4
STI
45
26
HSIC
45
5
PDCO
29
2
HAS
30
-2
LMT
30
-2
AA
56
15
D
40
2
DIS
85
3
MU
28
-3
SJM
9
-5
WM
74
-5
INTU
58
-3
CAH
48
-6
PFE
14
-7
GD
41
-4
EA
60
-5
IRM
41
3
AEP
54
6
SYY
49
9
VZ
44
4
STI
45
26
HSIC
45
5
PDCO
29
2
HAS
30
-2
LMT
30
-2
AA
56
15
D
40
2
DIS
85
3
MU
28
-3
Financhill
Back

First Republic Bank Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

FRCB
First Republic Bank

Last Price:
0.0100
Seasonality Move:
19.15%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.71
Seasonality Move:
17.03%
Sell
30
First Republic Bank (FRCB) is a Sell

Is First Republic Bank a Buy, Sell or Hold?

  • The current First Republic Bank [FRCB] share price is $0.0075. The Score for FRCB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • FRCB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FRCB Stock Price Chart

What is First Republic Bank's stock price today?

  • The First Republic Bank share price today is $0.0075
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FRCB is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FRCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 47.58 Sell
Chaikin Money Flow: -177220 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0077 - 0.0077) Sell
Bollinger Bands (100): (0.0033 - 0.0233) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FRCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.01 Buy
20-day SMA: 0.01 Sell
50-day SMA: 0.01 Sell
200-day SMA: 0.03 Sell
8-day EMA: 0.01 Buy
20-day EMA: 0.01 Sell
50-day EMA: 0.01 Sell
200-day EMA: 2.07 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Republic Bank Earnings Growth & FRCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

First Republic Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):